Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 201-247-9 | CAS number: 80-07-9
Endpoint summary
Administrative data
Description of key information
Key value for chemical safety assessment
Skin sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not sensitising)
- Additional information:
In the key dermal sensitisation study (Harlan CCR, 2010) with DCDPS in dimethylformamide, 4 female mice/dose level were tested at concentrations of 0, 5, 10, or 25 % (w/v) by means of the local lymph node assay (LLNA). During the course of the study, no signs of local irritation were noted. Low and mid dose group animals (5 and 10 %) showed no signs of systemic toxicity. In the high dose group (25 %), one animal died. The remaining animals at this dose level showed no symptoms of systemic toxicity. There was no effect of treatment on the body weights. The stimulation indices were 1.62, 0.83 and 1.00 at 5, 10 and 25 %, respectively. No EC3 value was established. Hexyl cinnamic aldehyde was used as positive control item and induced the appropriate response over background. Using the same dose levels as in the main assay, the EC3 value for the positive control item was 12.9 %. In this study, DCDPS was not a dermal sensitiser.
In the supporting dermal sensitisation study (ICI Ltd, 1970), using the technique of Stephens (1967), application of a 10 % solution of DCDPS to the ears of three albino guinea pigs for 3 days did not result in erythema when challenged with doses of 10, 1, and 0.1% four days later. It was concluded that the substance was not a dermal sensitiser.
Migrated from Short description of key information:
DCDPS was no dermal sensitiser in the key local lymph node assay (LLNA) performed according to test guideline OECD 429. In the supporting dermal sensitisation study performed in guinea pigs (abstract, reliability category 4) similarly no sensitising potential of DCDPS was noted.
Justification for classification or non-classification
Based on the key study result, 4,4'dichlorodiphenyl sulfone (DCDPS) is not subject to classification for sensitisation according to Directive 67/548/EEC and Regulation 1272/2008/EC.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
